Sodium Glucose Cotransporter 2 Inhibitor Market: How Are...

σε πρόσθεσε στο Health

2026-07-28 10:38:58 -

Sodium Glucose Cotransporter 2 Inhibitor Market: How Are Cardiorenal Benefits Expanding SGLT2i Indications Far Beyond Type 2 Diabetes?

Sodium-glucose cotransporter 2 inhibitors — the oral agents that block renal proximal tubular glucose reabsorption, producing glucosuria, osmotic diuresis, and natriuresis — have undergone one of the most remarkable therapeutic expansions in modern pharmacology, with the Sodium Glucose Cotransporter 2 Inhibitor Market reflecting the pivot from glucose-lowering drugs to foundational...

0 Σχόλια 0 Μοιράστηκε 545 Views 0 Προεπισκόπηση